CELESTICA INC

CLS

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 159,795Value: $47.2M

**Signal Note: Driehaus Capital initiates $47.2M position in Celestica** This appears to be a portfolio positioning error or data anomaly—Celestica is a contract electronics manufacturer (EMS), not a biotech company, making this an unusual entry for a growth-focused biotech fund. If accurate, the position likely reflects exposure to biotech manufacturing/supply chain consolidation rather than drug development assets, warranting clarification on investment thesis.

More CLS Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: